Antares takes cost-cutting measures:
This article was originally published in Clinica
Antares Pharma has decided to close its manufacturing and assembly facilities in Minneapolis, Minnesota, and outsource these activities. The company, which is developing needle-free injectors and transdermal gel products, says it wants to focus on design and engineering rather than investing its resources in expanding its production capabilities. The company restructured its debt financing earlier this month. Its partner, Ferring Pharmaceuticals, recently launched its Vision reusable device, and Lilly is examining the possibility of using its needle-free technology with several of its pharmaceuticals.